Educate

Community Forum - Educate

JOIN THE CONVERSATION

Last Reply:
Thanks so much for the quick response. Hearing the line "large mass in your scapula with probable neoplastic properties" threw me through a loop. I really expected bursitis. I'm hopeful it's...
Last Reply:
I understand Joanne. There are a million different ways to get thrown into the deep end of lung cancer and there's only so much understanding you can take in or find...
Last Reply:
I hope someone with experience will chime in. According to clinicians pleurex cath can be worn as long as it's functioning appropriately but at least several months.
Last Reply:
Janine, It's an interesting question. The schedule is one weekly drainage, and the doctor's order is not to drain any particular amount, but rather to drain however much fluid has accumulated...
Last Reply:
Hi Rowan, There is one active (but not currently recruiting) Phase I study testing the efficacy and safety of this combination: Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant...
Last Reply:
Thanks Judy :)
Last Reply:
Here are a few tidbits of tarlox info. https://www.globenewswire.com/news-release/2019/04/03/1796115/0/en/Rain-Therapeutics-Presents-Preclinical-Data-on-Lead-Candidate-Tarloxotinib-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html https://clincancerres.aacrjournals.org/content/27/5/1463 https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/first-analysis-of-rain-701-study-of-tarloxotinib-in-patients-with-non-small-cell-lung-cancer-nsclc-egfr-exon-20-insertion-her2-activating-mutat